Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00760851
Other study ID # 2008-01852
Secondary ID
Status Completed
Phase Phase 3
First received September 24, 2008
Last updated March 17, 2011
Start date September 2008
Est. completion date July 2010

Study information

Verified date February 2011
Source Georgetown University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the effectiveness of probiotics (popularly referred to as 'live active culture' or 'good bacteria') in preventing illnesses and consequent absences from school/daycare centers of children two to four years old that attend daycare at least 3 days per week. Two yogurt drinks will be administered, one containing a specific strain of probiotic, Bb-12. It is hypothesized that children receiving the Bb-12 drink will experience fewer illnesses and absences from daycare.

In this study, participants will be asked to:

1. Give their child 4 oz. of the test yogurt each day for 90 days

2. Keep a daily diary of their child's health

3. Collect 3 stool samples from their child at the start, middle, and end of the study

4. Speak with research personnel on a bi-weekly basis regarding their child's health

5. Ensure that their child to consume any yogurts or probiotic-containing products for 110 days of the study


Recruitment information / eligibility

Status Completed
Enrollment 190
Est. completion date July 2010
Est. primary completion date July 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 2 Years to 4 Years
Eligibility Inclusion Criteria:

- Child aged 2 to 4 years of age

- Child attends daycare at least 3 days per week

Exclusion Criteria:

- Caregiver does not speak English or Spanish

- Caregiver does not agree to have their child refrain from cultured dairy products (yogurt) for the 105-day duration of the study

- Caregiver does not agree to collect a stool sample from their child on Day 0, 45, and 105 of the study

- Caregiver does not have a refrigerator to store the yogurt product at home

- Child is currently receiving breast milk

- Child has an allergy or hypersensitivity to milk proteins or other dairy food components such as lactose

- Child has an allergy or hypersensitivity to strawberry or red food coloring

- Child has a chronic disease

- Child has had an infection or been sick 7 days prior to starting study

- Child has had diarrhea or constipation 7 days prior to starting study

- Child has a special diet as prescribed by a medical professional

- Child has received antibiotics, antiseptics, antifungal, corticosteroids, anti-histamines, non steroidal anti-inflammatory drugs within 7 days prior to starting the study

- Child has a congenital anomaly or birth defect that requires medical care

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention


Intervention

Other:
probiotic strain Bb-12
10^9 CFU Bb-12 per 4 oz yogurt
no Bb-12
yogurt identical to intervention yogurt, only without Bb-12 added.

Locations

Country Name City State
United States Georgetown University Department of Family Medicine, Research Division Washington District of Columbia

Sponsors (3)

Lead Sponsor Collaborator
Georgetown University Penn State University, United States Department of Agriculture (USDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary To determine if consumption of a yogurt drink containing Bb-12 decreases the number of absences children have from daycare/school due to illness 90 days No
Secondary Determine if the yogurt supplemented with Bb-12 results in overall improved parental satisfaction due to decreased illnesses in children attending daycare/school 90 No
See also
  Status Clinical Trial Phase
Completed NCT06283784 - Study To Evaluate The Efficacy of a Proprietary Mix of Live Probiotics In The Prophylaxis Of Diarrhea In Adult Patients N/A
Recruiting NCT03851835 - Multi-DOSE Oral Ondansetron for Pediatric Acute GastroEnteritis Phase 3
Completed NCT04003181 - The Pathogenesis of Chronic Diarrhoea After Treatment for Cancer in Cecum and the Ascending Colon N/A
Completed NCT03596827 - The Protective Immune Response to Attenuated Enterotoxigenic Escherichia Coli Infection N/A
Recruiting NCT05372068 - Cement flooRs AnD chiLd hEalth (CRADLE) N/A
Completed NCT03972618 - Evaluation of the Efficacy of Sawyer Point One Filters in Schools and Homes in the Dominican Republic N/A
Completed NCT05207618 - Utility of the Administration of Chesnut and Quebracho Extract for Irritable Bowel Syndrome Diarrhea Predominant N/A
Not yet recruiting NCT05052489 - Registry and Clinical Observation of Children With Diarrhoeal Disease
Completed NCT02541695 - Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli N/A
Completed NCT02428647 - Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation N/A
Completed NCT02197780 - Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD N/A
Completed NCT01968408 - Lactobacillus Reuteri DSM 17938 in Preventing Nosocomial Diarrhea in Children Phase 3
Completed NCT01739231 - Live Attenuated ETEC Vaccine ACE527 With and Without dmLT Adjuvant in Adults Phase 1/Phase 2
Terminated NCT01048567 - Efficacy and Safety of Lactobacillus Acidophilus/Rhamnosus Combination for the Prevention of Antibiotic-associated Diarrhea in the Elderly Phase 2
Terminated NCT01472211 - Water-based Zinc Intervention Trial in Zinc Deficient Children Phase 0
Not yet recruiting NCT01382199 - Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients Phase 3
Completed NCT01438645 - ScopeGuide-assisted Colonoscopy Versus Conventional Colonoscopy N/A
Completed NCT01371656 - Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation Phase 3
Completed NCT00914225 - Effect of Bednets and a Water Purification Device on HIV Disease Progression Among ART naïve Patients in Kenya N/A
Completed NCT00198796 - Dose-finding Study of WS6788A, DS37-4 and H10407 Enterotoxigenic Escherichia Coli (ETEC) Challenge Strains Phase 1